EXHIBIT 10.14 CONFIDENTIAL TREATMENT REQUESTED SOFTWARE LICENSE AGREEMENT Between Protein Design Labs, Inc. and Molecular Applications Group This Software License Agreement ("Agreement") is entered into by and among Protein Design Labs, Inc., a...Software License Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
EXHIBIT 10.15 CONFIDENTIAL TREATMENT REQUESTED DEVELOPMENT AND LICENSE AGREEMENT FOR HUMANISED [ ] between PROTEIN DESIGN LABS, INC. and SANDOZ PHARMA LTD. CONFIDENTIAL TREATMENT REQUESTED DEVELOPMENT AND LICENSE AGREEMENT This Agreement effective as...Development and License Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • London
EXHIBIT 10.13 CONFIDENTIAL TREATMENT REQUESTED AGREEMENT Effective as of July 1, 1990, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California ("STANFORD"), and PROTEIN...Confidential Treatment Requested Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
EXHIBIT 10.9 CONFIDENTIAL TREATMENT REQUESTED AGREEMENT This Agreement is entered into as of January 31, 1989 ("Effective Date"), by and between F. HOFFMANN-LA ROCHE & CO. LIMITED COMPANY of Basle, Switzerland ("F. Roche) and PROTEIN DESIGN LABS,...Confidential Treatment Requested Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
DEVELOPMENT AND LICENSE AGREEMENT FOR HUMANIZED MONOCLONAL ANTIBODIES AGAINST gpllb/llla between PROTEIN DESIGN LABS, INC. and YAMANOUCHI PHARMACEUTICAL COMPANY, LTD. DEVELOPMENT AND LICENSE AGREEMENT Effective 12 February 1991 ("Effective Date"),...Development and License Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
EXHIBIT 10.8 CONFIDENTIAL TREATMENT REQUESTED AGREEMENT This Agreement is entered into as of January 31, 1989 ("Effective Date"), by and between HOFFMANN-LA ROCHE INC., a New Jersey corporation having offices at 340 Kingsland Street, Nutley, New...Confidential Treatment Requested Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
EXHIBIT 10.7 CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT This Agreement is entered into between the National Technical Information Services (NTIS), a primary operating unit of the United States Department of Commerce, having offices at 5285...Confidential Treatment Requested License Agreement • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • District of Columbia
AGREEMENTConfidential Treatment Requested • May 26th, 1998 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • California
